Coherus BioSciences, Inc. (CHRS)
USD 0.97
(16.59%)
USD 0.97
(16.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 257.24 Million | 211.04 Million | 326.55 Million | 475.82 Million | 356.07 Million | 1.55 Million |
| Cost of Revenue | 162.78 Million | 70.08 Million | 57.59 Million | 37.66 Million | 17.07 Million | 3.23 Million |
| Gross Profit | 94.46 Million | 140.95 Million | 268.96 Million | 438.15 Million | 338.99 Million | -1.67 Million |
| Operating Expenses | 301.45 Million | 397.83 Million | 532.81 Million | 281.83 Million | 231.22 Million | 204.41 Million |
| Selling, General and Administrative Expenses | 185.61 Million | 198.48 Million | 169.71 Million | 139.07 Million | 137.03 Million | 94.17 Million |
| Research and Development Expenses | 109.43 Million | 199.35 Million | 363.1 Million | 142.75 Million | 94.18 Million | 110.23 Million |
| Other Expenses | - | 3.82 Million | -283 Thousand | 554 Thousand | 2.6 Million | 4.69 Million |
| Cost and Expenses | 460.44 Million | 467.92 Million | 590.4 Million | 319.5 Million | 248.3 Million | 204.41 Million |
| Operating Income | -203.19 Million | -256.88 Million | -263.85 Million | 156.31 Million | 107.76 Million | -204.41 Million |
| Interest Expense | 40.54 Million | 32.47 Million | 22.95 Million | 21.16 Million | 17.6 Million | 9.68 Million |
| Income Tax Expense | -380 Thousand | 34.87 Million | 19.22 Million | 3.46 Million | 2.94 Million | 4.69 Million |
| Earnings before Tax | -238.27 Million | -291.75 Million | -287.1 Million | 135.7 Million | 92.77 Million | -209.4 Million |
| Net Income | -237.89 Million | -326.62 Million | -306.32 Million | 132.24 Million | 89.83 Million | -209.33 Million |
| Earnings Per Share Basic | -2.53 | -4.21 | -4.06 | 1.85 | 1.29 | -3.22 |
| Earnings Per Share Diluted | -2.53 | -4.21 | -4.06 | 1.62 | 1.23 | -3.22 |
| Weighted Average Shares Outstanding | 94.16 Million | 77.63 Million | 75.44 Million | 71.41 Million | 69.67 Million | 65.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 94.16 Million | 77.63 Million | 75.44 Million | 83.49 Million | 73.18 Million | 65.03 Million |
| Gross Margin | 0.37 | 0.67 | 0.82 | 0.92 | 0.95 | -1.08 |
| EBIT Margin | -0.75 | -1.20 | -0.81 | 0.33 | 0.31 | -128.36 |
| Profit Margin | -0.92 | -1.55 | -0.94 | 0.28 | 0.25 | -134.54 |
| EBITDA | -193.93 Million | -255.58 Million | -260.68 Million | 161.84 Million | 111.02 Million | -204.41 Million |
| Earnings Before Tax Margin | -0.79 | -1.22 | -0.81 | 0.33 | 0.30 | -131.37 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 64.97 Million | 77.06 Million | 91.52 Million | 257.24 Million | 74.56 Million | 58.71 Million |
| Cost of Revenue | 29.55 Million | 36.09 Million | 85.63 Million | 162.78 Million | 32.7 Million | 24.84 Million |
| Gross Profit | 35.42 Million | 40.97 Million | 5.89 Million | 94.46 Million | 41.86 Million | 33.86 Million |
| Operating Expenses | 55.93 Million | 76.69 Million | 74.25 Million | 287.66 Million | 73.87 Million | 68.41 Million |
| Selling, General and Administrative Expenses | 35.16 Million | 49.73 Million | 48.94 Million | - | 48.22 Million | 45.14 Million |
| Research and Development Expenses | 20.76 Million | 26.96 Million | 25.3 Million | - | 25.64 Million | 23.26 Million |
| Other Expenses | 1.46 Million | 2.86 Million | -129 Thousand | 5.46 Million | 2.25 Million | 1.61 Million |
| Cost and Expenses | 85.48 Million | 112.78 Million | 159.88 Million | 450.44 Million | 106.57 Million | 93.25 Million |
| Operating Income | -20.5 Million | -35.72 Million | -68.36 Million | -193.19 Million | -32 Million | -34.54 Million |
| Interest Expense | 5.33 Million | 11.11 Million | 10.61 Million | 40.54 Million | -10.26 Million | 9.94 Million |
| Income Tax Expense | - | 1.46 Million | -10.61 Million | -380 Thousand | -380 Thousand | 11.56 Million |
| Earnings before Tax | -12.92 Million | 102.87 Million | -79.65 Million | -238.27 Million | -40.02 Million | -42.86 Million |
| Net Income | -12.92 Million | 102.87 Million | -79.65 Million | -237.89 Million | -39.64 Million | -42.86 Million |
| Earnings Per Share Basic | -0.11 | 0.91 | -0.71 | - | -0.41 | -0.49 |
| Earnings Per Share Diluted | -0.11 | 0.82 | -0.71 | - | -0.41 | -0.49 |
| Weighted Average Shares Outstanding | 114.81 Million | 112.74 Million | 111.49 Million | 94.16 Million | 97.73 Million | 87.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 114.81 Million | 125.52 Million | 111.49 Million | 94.16 Million | 97.73 Million | 87.26 Million |
| Gross Margin | 0.55 | 0.53 | 0.06 | 0.37 | 0.56 | 0.58 |
| EBIT Margin | -0.30 | -0.44 | -0.74 | - | -0.43 | -0.55 |
| Profit Margin | -0.20 | 1.33 | -0.87 | -0.92 | -0.53 | -0.73 |
| EBITDA | -19.32 Million | -34.21 Million | -67.29 Million | - | -32 Million | -32.04 Million |
| Earnings Before Tax Margin | -0.32 | -0.46 | -0.75 | -0.75 | -0.43 | -0.59 |
8016
5520
ACEJF
SBET
AMAN
6599